SCHEDULE 13G

Statement of Beneficial Ownership

Protalix BioTherapeutics, Inc. Filed 2026-03-04 Acc 0001426156-26-000002

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-07-29 SCHEDULE 13G Statement of Beneficial Ownership
2026-03-09 8-K Other events
2026-03-04 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)